110 ALLEN ROAD, BASKING RIDGE, NJ
Lisata Therapeutics Enters Amendment to Merger Agreement with Kuva Labs
Other Events
Waiver to Agreement and Plan of Merger
Ex-99.1
Lisata Therapeutics Enters Agreement for Acquisition by Kuva Labs
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Tender Offer Statement by Third Party
Solicitation/Recommendation Statement
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Correspondence
Submission Upload